Glucotrack (GCTK) Change in Accured Expenses (2010 - 2025)
Glucotrack (GCTK) posted Change in Accured Expenses of -$255000.0 for Q4 2025, down 321.74% on a QoQ basis from $115000.0 in Q3 2025, and up 42.95% year-over-year from -$178380.3 in Q4 2024.
Glucotrack (GCTK) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Glucotrack's Change in Accured Expenses history runs 14 years deep, the most recent figure standing at -$255000.0 for Q4 2025.
- Quarterly Change in Accured Expenses rose 42.95% year-over-year to -$255000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17000.0 (up 104.04% YoY) and the FY2025 annual result came in at $17000.0, up 104.04% from the prior year.
- Change in Accured Expenses was -$255000.0 for Q4 2025 at Glucotrack, down from $115000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $466000.0 in Q4 2023 and bottomed at -$447000.0 in Q4 2024.
- A 5-year average of -$5300.0 and a median of $5500.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 435.63% — and 2024, when it tumbled 1346.15%.
- Glucotrack's Change in Accured Expenses stood at -$30000.0 in 2021, then soared by 390.0% to $87000.0 in 2022, then surged by 435.63% to $466000.0 in 2023, then plunged by 195.92% to -$447000.0 in 2024, then soared by 42.95% to -$255000.0 in 2025.
- Business Quant data shows GCTK's Change in Accured Expenses at -$255000.0 in Q4 2025, $115000.0 in Q3 2025, and $106000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 124.86 Bn | 119.64 Bn | 1.96 Bn | -260.40 Mn |
| 2 | Becton Dickinson | 44.42 Bn | 43.60 Bn | 2.15 Bn | - |
| 3 | Alcon | 33.14 Bn | 31.48 Bn | 1.53 Bn | - |
| 4 | Medline | 32.66 Bn | 30.42 Bn | 1.84 Bn | -32.00 Mn |
| 5 | Resmed | 29.13 Bn | 27.47 Bn | 890.98 Mn | 103.88 Mn |
| 6 | West Pharmaceutical Services | 23.50 Bn | 23.06 Bn | 329.20 Mn | - |
| 7 | Solventum | 13.88 Bn | 13.32 Bn | 1.10 Bn | -151.00 Mn |
| 8 | Cooper Companies | 13.84 Bn | 13.70 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.13 Bn | 11.07 Bn | 736.59 Mn | 5.38 Mn |
| 10 | Glucotrack | 183,719.61 | -7.20 Mn | - | -255,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -255,000.00 |
| Dec 31, 2025 | -255,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | -447,000.00 |
| Dec 31, 2024 | -447,000.00 |
| Sep 30, 2024 | -188,000.00 |
| Sep 30, 2024 | -188,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Mar 31, 2024 | -229,000.00 |
| Mar 31, 2024 | -229,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Sep 30, 2023 | -13,000.00 |